Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

COVID-19

× Close UK HealthCare Coronavirus Information Hub Arrow Pointing Right

Ahmed K. Abdel-Latif, MD, MSc, PhD

Why are there no ratings?
Dr. Ahmed Abdel-Latif
Request an Appointment Physician Referral

Specialties

  • Cardiac Catheterization and Interventions
  • Cardiovascular Medicine
  • Heart Attack Emergency Care
  • Peripheral Arterial Disease

  • About

    Ahmed K. Abdel-Latif earned his medical degree from Ain Shams University in Cairo before completing his residency in internal medicine and a research fellowship in vascular medicine at Cleveland Clinic. He later completed fellowships in cardiology at the University of Louisville, where he served as chief fellow, and in interventional cardiology at UK HealthCare.

    Abdel-Latif’s interest in research and translational science – including a deep interest in stem cell biology – led him to earn his Master of Science degree, with a focus in clinical investigation, at the University of Louisville, followed by a PhD in immunology and molecular biology at UK.

    Abdel-Latif practices as an interventional cardiologist at UK HealthCare and performs cardiac catheterizations and interventions. He also holds an appointment as an associate professor of cardiology in the UK College of Medicine. He is actively engaged in both basic and translational research related to stem cell therapy for heart disease. Abdel-Latif has co-authored more than 100 peer-reviewed journal manuscripts and several book chapters.

    Personal Statement

    I think the most important thing as a physician, and especially in this particular area of clinical work, is to understand the major lifestyle limitations that patients face because of their disease and to be compassionate. Over the years, we have developed the necessary tools and access to the latest therapies needed to improve a patient’s clinical situation. One of these unique tools we have in our arsenal in the Cardiology Division at UK is our access to the latest clinical trials. This puts us at the forefront of the latest advances in cardiac care and allows our patients to undergo the latest and most successful therapies that are still in the pre-clinical stage.

    Faculty Rank

    Associate Professor of Medicine

    Degree

    Ain Shams University, Cairo, Egypt

    Residency

    Cleveland Clinic Foundation, Cleveland

    Fellowship

    University of Kentucky

    Certifications and Special Training

    American Board of Internal Medicine

    American Board of Internal Medicine, Cardiovascular Disease

Are you happy with the care you received from this provider?

Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.

Leave a review

  • Publications

    1. Cardiac Chemical Exchange Saturation Transfer MR Imaging Tracking of Cell Survival or Rejection in Mouse Models of Cell Therapy. Radiology. 2016 Jul 15;152766. Pumphrey AL, Ye S, Yang Z, Simkin J, Gensel JC, Abdel-Latif A, Vandsburger MH.
      View Publication
    2. Radiofrequency and Cryoablation Effect on Transvenous Pacing and Defibrillatory Lead Integrity: An in vitro study. J Cardiovasc Electrophysiol. 2016 May 3. Darrat YH, Agarwal A, Morales GX, Thompson J, Abdel-Latif A, Waespe K, Biase LD, Natale A, Patwardan A, Elayi CS.
      View Publication
    3. Evidence that a lipolytic enzyme-hematopoietic-specific phospholipase C-β2-promotes mobilization of hematopoietic stem cells by decreasing their lipid raft-mediated bone marrow retention and increasing the promobilizing effects of granulocytes. Leukemia. 2016 Apr;30(4):919-28. Adamiak M, Poniewierska-Baran A, Borkowska S, Schneider G, Abdelbaset-Ismail A, Suszynska M, Abdel-Latif A, Kucia M, Ratajczak J, Ratajczak MZ.
      View Publication
    4. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2016 Mar;87(4):722-32. Ziada KM, Abdel-Latif A, Charnigo R, Moliterno DJ.
      View Publication
    5. Circulating Endothelial Cells and Endothelial Function Predict Major Adverse Cardiac Events and Early Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction. J Interv Cardiol. 2016 Feb;29(1):89-98. Abdel Hamid M, Bakhoum SW, Sharaf Y, Sabry D, El-Gengehe AT, Abdel-Latif A.
      View Publication